 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
News Briefs Glaxo Faces Amended Suit Over HIV DrugsOctober 16, 2002 GlaxoSmithKline is facing new allegations in an antitrust lawsuit that AIDS Healthcare Foundation filed in Los Angeles in July, challenging the lack of generic competition for the company's two HIV drugs. The foundation alleges that Glaxo lied to the US Patent and Trademark Office when it sought a patent on Retrovir, known as AZT and a key ingredient in both drugs. The lawsuit says Glaxo did not invent AZT nor did it conduct the research showing AZT's use in fighting HIV. "We never claimed to have invented AZT," said a Glaxo spokesperson. Scientists with a Glaxo predecessor "identified its use in the treatment of AIDS." Los Angeles Times 10.15.02; Bloomberg News  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
